Reply to: "Biejia-Ruangan compound and incidence of hepatocellular carcinoma"
J Hepatol
.
2023 Apr;78(4):e142-e144.
doi: 10.1016/j.jhep.2023.01.003.
Epub 2023 Jan 13.
Authors
Dong Ji
1
,
Lin Tan
2
,
Yongping Yang
3
Affiliations
1
Senior Department of Hepatology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
2
Liver Disease Department, The Second People's Hospital of Fuyang City, Fuyang, Anhui, China.
3
Senior Department of Hepatology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China. Electronic address: yongpingyang@hotmail.com.
PMID:
36646213
DOI:
10.1016/j.jhep.2023.01.003
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Carcinoma, Hepatocellular* / epidemiology
Humans
Incidence
Liver Neoplasms* / epidemiology